⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Riyadh Global Medical Biotechnology Summit 2026 Closes as a Major Success with SAR 5.5 Billion in Agreements and announcement, Confirming Saudi Arabia's Commitment to Lead the Future of Biotechnology
globenewswire.com
TMO
NVO
Novo: CHMP recommends EU approval of FREHEMGO® (denecimig), the first factor VIIIa mimetic offering monthly, once every two weeks and weekly dosing in a pre-filled pen, for the treatment of haemophilia A
globenewswire.com
NVO
Orbis Medicines Enters Multi-Target Drug Discovery Partnership with Novo Nordisk Worth up to USD 1.4 Billion
businesswire.com
NVO
Novo and Anthropic will collaborate to advance drug discovery with Claude
globenewswire.com
NVO
AI
GLP-1 Therapies Market Set for Rapid Growth Through 2034 as Obesity and Diabetes Demand, Drug Innovation, and Expanding Indications Fuel New Business Opportunities
globenewswire.com
NVO
LLY
AZN
SNY
GSK
NACTOY Reveals 2027 Award Contenders
prnewswire.com
GM
RIVN
TM
VWAGY
VOW3.DE
STLA
HMC
F
MSFT
NVDA
GOOGL
GOOG
TSLA
KMX
VLO
XOM
CVX
LYFT
UBER
AVGO
QCOM
AMD
INTC
AMZN
AAPL
META
NFLX
DIS
CMCSA
VZ
T
BA
GD
LMT
RTX
HON
GE
CAT
DE
MMM
AXP
JPM
BAC
WFC
GS
MS
C
PFE
JNJ
MRK
ABBV
BMY
GILD
AMGN
LLY
NVO
AZN
SNY
TEVA
BIIB
REGN
VRTX
GPRO
CRSP
EDIT
NTLA
BNTX
MRNA
COIN
PYPL
MARA
RIOT
PLTR
AI
UPST
SOFI
HOOD
MU
AMAT
LRCX
KLAC
ASML
ADI
NXPI
ON
MCHP
SNPS
CDNS
SSYS
GEHC
ISRG
MDLZ
PEP
KO
MCD
SBUX
NKE
TGT
WMT
HD
LOW
COST
MGM
LVS
WYNN
CCL
RCL
NCLH
AAL
DAL
UAL
LUV
ALK
JBLU
MitoRx Therapeutics Appoints Clinical & Scientific Advisory Board to Guide the Development of MTRX31
globenewswire.com
NVO
ABBV
AZN
LLY
China's TEDA Transforms from Investment Magnet to Competitive Industrial Hub via Industrial-chain Upgrade
globenewswire.com
OTIS
NVO
Oligonucleotide Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Ionis Pharmaceuticals, and Sarepta Therapeutics
globenewswire.com
ALNY
IONS
SRPT
BIIB
NVS
AZN
NVO
SNY
ARWR
Novo Nordisk enters next chapter to bring better health to more people, supported by ‘Novo’ rebrand and updated corporate culture
globenewswire.com
NVO